Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in GermanyBjörn‐Erik Ole Jensen, Tom Luedde, Torsten Feldt et al.|The Lancet Regional Health - Europe|2021Cited by 117